Organ Preservation Solutions - Global Strategic Business Report

  • ID: 1244799
  • Report
  • Region: Global
  • 128 Pages
  • Global Industry Analysts, Inc
1 of 4
The report provides separate comprehensive analytics for the US, Canada, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.

This report analyzes the worldwide markets for Organ Preservation Solutions in US$ Thousand.

Company profiles are primarily based on public domain information including company URLs.

The report profiles 20 companies including many key and niche players such as:
  • 21st Century Medicine
  • BioLife Solutions, Inc.
  • Dr. Franz Köhler Chemie GmbH
  • Essential Pharmaceuticals, LLC
  • Lifeline Scientific, Inc.
  • Preservation Solutions, Inc.
Note: Product cover images may vary from those shown
2 of 4

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW
A Prelude
Major Growth Drivers in a Gist
Key Growth Restraints
Table 1: Comparison of Major Organ Preservation Solutions
Current & Future Market Analysis
Geographic Landscape
Competitive Scenario
Table 2: Global Organ Preservation Solutions Market (2011 & 2015): Percentage Breakdown of Dollar Sales for Perfadex, Hypo Thermosol, Custodiol® HTK, Renograf, Viaspan, and Others (includes corresponding Graph/Chart)
Custodiol HTK Gains Prominence vs. the Gold Standard UW Solution
XVIVO Sees Brighter Prospects in Organ Preservation Products
Contamination Concerns with Regard to ViaSpan®
Organ Preservation Techniques
Simple Cold Storage
Continuous Hypothermic Perfusion/Hypothermic Perfusion Preservation

2. MARKET TRENDS AND GROWTH DRIVERS
Growing Awareness and Policy Support on Transplantation to Benefit Market Growth
EVLP: Revolutionary Technique for Lung Preservation
New Paradigms in Heart and Lung Preservation
Organ Banking: Glimpse into the Future?
Preservation Solutions
A Key to Deceased Donor Transplants
Euro-Collins Extending Opportunities in the Kidney Segment
Cardiac Preservation Scenario Remains Static
UW
The Gold Standard in Heart Preservation
Innovative Organ Preservation Solutions on the Horizon
A Focus on Leeds Solutions
Lungs Preservation in Search of Ideal Solution
Scientists See Cryopreservation as a Potential Means for Organ Preservation
UW and HTK Find Growing Use in Abdominal Organ Preservation
UW Vs. HTK in Liver Transplantation
Supercooling Organs
A New Approach to Extend Storage Life
Measures to Address Organ Shortage to Infuse Demand for Preservation Solutions
Machine Perfusion Gains Popularity over Cold Storage
Is Warm Perfusion the Next Standard in Organ Preservation?
Key Organ Transplantation Statistics
Table 3: Global Kidney Transplant Activity by Source (2016): Number of Kidney Transplants from Living and Deceased Donors for Select Leading Countries (includes corresponding Graph/Chart)
Table 4: Global Liver Transplant Activity by Source (2016): Number of Liver Transplants from Living and Deceased Donors for Select Leading Countries (includes corresponding Graph/Chart)
Table 5: Global Heart Transplant Activity (2016): Number of Heart Transplants for Select Leading Countries (includes corresponding Graph/Chart)
Living Donors on the Rise
Graying Population and Chronic Diseases Surge Need for Transplants
Table 6: Elderly Population (65+ Years) as a % of Total Population (2000 & 2025P) (includes corresponding Graph/Chart)
Transplant Tourism
Creating Brighter Avenues
Combined Organ Transplantation
Gaining Attention
Table 7: Multiple Organ Transplants in the US
No. of Transplants by Type (2010-2015)
Cardiac Arrest Death Patients
The Untapped Potential Donors
Table 8: Leading Countries in Terms of Number of Donors after Cardiac Death (DCD): 2016 (includes corresponding Graph/Chart)

3. PRODUCT OVERVIEW
Organ Preservation Solutions
Elements and Functions of Organ Preservation Solutions
Technical Specifications of the Organ Preservation Solutions
Solutions in Concentrated Form
Steps in Organ Preservation
Identification of the Donor
Organ Removal
Organ Recovery and Preservation
Organ Preservation Techniques
Hypothermia
Requirements of Ideal Preservation Solution
Factors Determining Organ Viability
Storage Duration Time
Storage Time Period for Organs and Tissues
Factors Impacting the Organ Preservation
Hypothermia Induced Cell Swelling
Cellular Acidosis and ATP Usage
Compromised Membrane Function
Functions of Organ Preservation Solutions
Prevention of Reactive Oxygen Species Formation
Reduction of Cell Swelling
Prevention of Cellular Acidosis
Benefits with Colloids
Secondary Functions
Production and Packaging
Production
Packaging
Tests for Organ Preservation Solutions
Hydroxymethylfurfural Test
Particulate Contamination
Test for Pyrogens
Static Cold Storage
The Most Applied and Popular Technique
Vitrification
A Promising Cryopreservation Approach for Whole Organs
Select Products
Euro Collins Solution
Table 9: Composition of Euro-Collins Solution (includes corresponding Graph/Chart)
University of Wisconsin (UW) Solution
Table 10: Composition of UW Solution
Custodiol® Histidine-Tryptophan-Ketoglutarate (HTK) Solution
Table 11: Composition of Custodial HTK Solution
Advantages
Disadvantages
Major Clinical Differences between Custodiol HTK and Viaspan
Celsior Solution
Table 12: Composition of Celsior Solution
Hypothermosol
Perfadex®
Advantages
Ross-Marshall Citrate Solutions
Phosphate-Buffered Sucrose Solution
Lifor
IGL-1
HBS Solution
ET-Kyoto
Table 13: Composition of ET-Kyoto Solution
Polysol
TranSend
Background
Organ Transplantation
A Prelude
Heart Transplantation
Heart Diseases and Disorders
Post-Operative Complications and Consequences of Heart Transplants
Kidney Transplantation
Kidney Disorders and Diseases
Donor Evaluation
Waiting List
Surgery/Post-Operation
Post-Operative Supervision and Issues
Liver Transplantation
Liver Disorders and Diseases
Pancreas Transplantation
Post-Operative Complications and Consequences of Pancreas Transplants
Small Intestine Transplantation
Intestine Disorders and Diseases
Heart-and-Lung Transplantation
Lung Transplantation
Lung Diseases and Disorders
Lung Patients Survival Statistics
Transplantation Immunology
Acute Cellular Rejection
Chronic Rejection
Post-Transplant Observations
Types of Donors
Alive Donors
Related Donors
Good Samaritans
Rewarded/Forced Donors
Deceased Donors
Directed / Allocated
Organs Transplanted by Type of Donor
Organ Donation and Eligibility Criteria
Factors Considered for Matching Recipients to Donor Organs
Testing
Blood Typing
Tissue Typing
Issues Impacting Transplantation Market
Scarcity of Donor Organs
Organ Rejection
Other Issues
Ethical Concerns and Bioethical Issues
Lack of Requisite Expertise
Transplantation
Safety Requirements
Waiting List
Active Waiting List Patients
Inactive Waiting List Patients
Transplantation Expenses
Major Medical and Non-Medical Expenses

4. RECENT INDUSTRY ACTIVITY
BioLife and TissueGene Ink Supply Agreement
BioLife and Promethera Embed CryoStor into HepaStem Manufacturing
BioLife and Bellicum Ink Supply Deal for CryoStor
Cook Embeds BioLife’s Media Products into Autologous Cell Therapy
BioLife and Kite Pharma Ink Supply Agreement
Paragonix and Waters Sign Product Supply Agreement
Paragonix Technologies Announces Publication of Sherpa Pak™ Transport Systems
CFDA Approves Organ Preservation Solutions by Lifeline Scientific
Provepharm Enters Into Partnership with DFKC

5. FOCUS ON SELECT KEY PLAYERS
21st Century Medicine (USA)
BioLife Solutions, Inc. (USA)
Dr. Franz Köhler Chemie GmbH (Germany)
Essential Pharmaceuticals, LLC (USA)
Lifeline Scientific, Inc. (USA)
Preservation Solutions, Inc. (USA)
XVIVO Perfusion AB (Sweden)

6. GLOBAL MARKET PERSPECTIVE
Table 14: World Recent Past, Current & Future Analysis for Organ Preservation Solutions by Geographic Region
US, Canada, Europe, Asia-Pacific, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 15: World Historic Review for Organ Preservation Solutions by Geographic Region
US, Canada, Europe, Asia-Pacific, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 16: World 14-Year Perspective for Organ Preservation Solutions by Geographic Region
Percentage Breakdown of Dollar Sales for US, Canada, Europe, Asia-Pacific, and Rest of World Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES
A. Market Analysis
Increasing Number of Organ Transplants Drives the Organ Preservation Market
Table 17: Organ Transplantation in the US by Organ: Number of Transplants for Select Organs for Years 2013-2017 (includes corresponding Graph/Chart)
Table 18: US Kidney Transplants by Donor Type
Deceased and Living: Number of Procedures for 2013-2016 (includes corresponding Graph/Chart)
Table 19: US Liver Transplants by Donor Type
Deceased and Living: Number of Procedures for 2013-2016 (includes corresponding Graph/Chart)
Table 20: US Heart Transplants by Donor Type
Deceased and Living: Number of Procedures for 2013-2016 (includes corresponding Graph/Chart)
Table 21: US Lung Transplants by Donor Type
Deceased and Living: Number of Procedures for 2013-2016 (includes corresponding Graph/Chart)
Table 22: US Pancreas Transplants by Donor Type
Deceased and Living: Number of Procedures for 2013-2016 (includes corresponding Graph/Chart)
Table 23: US Intestinal Transplants by Donor Type
Deceased and Living: Number of Procedures for 2013-2016 (includes corresponding Graph/Chart)
Ever-Increasing Waiting Lists Create Demand for Proper Organ Preservation
Table 24: US Waiting List of Patients for Organ Transplants by Organ Type: 2017 (includes corresponding Graph/Chart)
Organ Bioengineering and Banking to Unleash New Opportunities
New FDA Warning on Contamination Shakes the Market
Strategic Corporate Developments
Select Key Players
B. Market Analytics
Table 25: US Recent Past, Current & Future Analysis for Organ Preservation Solutions Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 26: US Historic Review for Organ Preservation Solutions Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)

2. CANADA
Market Analysis
Table 27: Canadian Recent Past, Current & Future Analysis for Organ Preservation Solutions Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 28: Canadian Historic Review for Organ Preservation Solutions Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)

3. EUROPE
A. Market Analysis
Current & Future Analysis
Focus on Select Key Regional Markets
Italy
The United Kingdom
Table 29: Deceased Organ Donations for Transplants in the UK: Number of Organs by Type for Years FY 2016 and FY 2017 (includes corresponding Graph/Chart)
Table 30: Living Organ Donations for Transplants in the UK: Number of Organs by Type for Years FY 2016 and FY 2017 (includes corresponding Graph/Chart)
Table 31: UK Active Transplant List by Organ Type for Years FY 2016 and FY 2017 (includes corresponding Graph/Chart)
Strategic Corporate Development
Select Key Players
B. Market Analytics
Table 32: European Recent Past, Current & Future Analysis for Organ Preservation Solutions Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 33: European Historic Review for Organ Preservation Solutions Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)

4. ASIA-PACIFIC
A. Market Analysis
Current & Future Analysis
Select Regional Markets
Australia
Table 34: Australia Organ Transplantations by Organ Type: 2015 (includes corresponding Graph/Chart)
Table 35: Australian Organ Transplants by State: 2015 (includes corresponding Graph/Chart)
China
Cost Efficiency Lures Transplant Patients from Overseas
India
Overview of Renal Transplantation
Low Transplantation Expenses Boost Medical Tourism
Singapore
Awareness Programs to Increase Living Kidney Donations in Singapore
Strategic Corporate Development
B. Market Analytics
Table 36: Asia-Pacific Recent Past, Current & Future Analysis for Organ Preservation Solutions Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 37: Asia-Pacific Historic Review for Organ Preservation Solutions Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)

5. REST OF WORLD
A. Market Analysis
Current & Future Analysis
Select Regional Markets
Latin America
Brazil
A Major Transplant Market
The Middle East
Kuwait
A Rapidly Emerging ‘Third World’ Country in Organ Transplants
Iran
“Kidney E-Bay”
B. Market Analytics
Table 38: Rest of World Recent Past, Current & Future Analysis for Organ Preservation Solutions Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 39: Rest of World Historic Review for Organ Preservation Solutions Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 20 (including Divisions/Subsidiaries 22)

  • The United States (12)
  • Europe (8)
    • France (2)
    • Germany (1)
    • The United Kingdom (2)
    • Italy (1)
    • Rest of Europe (2)
  • Asia-Pacific (Excluding Japan) (2)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • 21st Century Medicine (USA)
  • BioLife Solutions, Inc. (USA)
  • Dr. Franz Köhler Chemie GmbH (Germany)
  • Essential Pharmaceuticals, LLC (USA)
  • Lifeline Scientific, Inc. (USA)
  • Preservation Solutions, Inc. (USA)
  • XVIVO Perfusion AB (Sweden)
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll